Udy Andrew A, Schweikert Sacha, Anstey James, Anstey Matthew, Cohen Jeremy, Flower Oliver, Saxby Edward, Poll Andrew van der, Delaney Anthony
Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
Intensive Care Unit, Sir Charles Gairdner Hospital, Perth, WA, Australia.
Crit Care Resusc. 2017 Jun;19(2):103-109.
Patients with an aneurysmal subarachnoid haemorrhage (SAH) frequently require admission to the intensive care unit. There, a variety of therapeutic strategies are initiated, in addition to definitive procedures aimed at securing the aneurysm. Despite a substantial investment in caring for these patients, outcomes for this group remain poor. Although the severity of the initial bleed is crucial in this context, many patients undergo further deterioration in the ICU. Delayed cerebral ischaemia is a significant cause of longterm morbidity and mortality after SAH. There are limited data supporting much of the critical care provided to patients with SAH in the ICU, leading to substantial institutional and practitioner variation in treatment. Whether this influences patient outcomes is unknown, although it represents a major knowledge gap in neurocritical practice in Australia and New Zealand.
患有动脉瘤性蛛网膜下腔出血（SAH）的患者经常需要入住重症监护病房。在那里，除了旨在固定动脉瘤的确定性手术外，还会启动各种治疗策略。尽管在护理这些患者方面投入了大量资源，但该组患者的预后仍然很差。虽然在这种情况下初始出血的严重程度至关重要，但许多患者在重症监护病房会进一步恶化。迟发性脑缺血是SAH后长期发病和死亡的重要原因。支持在重症监护病房为SAH患者提供的许多重症护理的数据有限，导致治疗在机构和从业者之间存在很大差异。尽管这代表了澳大利亚和新西兰神经重症实践中的一个重大知识空白，但它是否会影响患者预后尚不清楚。
